Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Advises Lombard Medical in U.S. IPO and Re-domicile

May 1, 2014

LONDON, 1 May, 2014 — Covington & Burling advised Lombard Medical, Inc. on its $55 million U.S. initial public offering and the listing of the company’s ordinary shares on the NASDAQ Global Market. Covington also advised the company on its change of domicile from the U.K. to the Cayman Islands and the delisting of its shares from the AIM market of the London Stock Exchange.

Lombard Medical, Inc. is the Cayman Islands parent company of Lombard Medical Technologies PLC, a medical device company focused on device solutions for the $1.4 billion abdominal aortic aneurysm repair market.

The Covington team that advised on the change of domicile and delisting process was led by Natalie Walter and included Matt Edwards and Sarah Hoult (corporate); and Guy Dingley (tax). The Covington team that advised on the U.S. initial public offering was led by Kristian Wiggert and included Brian Rosenzweig, Philip Young, Aysha Qureshi, Lilit Kazangyan and Sarah Griffiths (corporate); Ellen Flannery, Anna Kraus, David Lorello, Stefanie Doebler, Robin Blaney and Mingham Ji (regulatory); Rob Heller (tax); and legal opinion assistance from James Gubbins, Hilary Prescott and Gus Caywood.

Share this article: